Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.

After excluding patients with mantle cell lymphoma, we analyzed OS in the remaining 409 patients with indolent NHL: the patients in the high BMI group showed longer OS with 85.0% of patients alive at 5 years versus 70.2% in the low BMI group (HR 0.581; 95%CI 0.331–1.022; p = 0.059). Of interest, there was a slight trend for longer PFS in the high BMI group when compared to the low BMI group, which however did not reach statistical significance (HR 0.798; 95%CI 0.586–1.087; p = 0.152), with 42.5% of patients without progression after 5 years in the high BMI group versus 32.9% in the low BMI group (Fig. 1 b).

also in 4,078 other papers